Improving global health governance to combat counterfeit medicines: A proposal for a UNODC-WHO-Interpol trilateral mechanism

BMC Medicine

Volumn 11, Issue 1, 2013, Pages

  Mackey, Tim K ^a,b,c   Liang, Bryan A ^a,b  

^a University of California at San Diego   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CALIFORNIA WESTERN SCHOOL OF LAW   (United States)

Author keywords

Counterfeit medicines; Drug supply chain; Falsified medicines; Fraudulent medicines; Global health governance; Global health policy; Substandard medicines

Indexed keywords

COUNTERFEIT DRUG;

ARTICLE; DRUG SURVEILLANCE PROGRAM; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; PATIENT SAFETY; PUBLIC HEALTH; PUBLIC HEALTH PROBLEM; PUBLIC-PRIVATE PARTNERSHIP; UNITED NATIONS; WORLD HEALTH ORGANIZATION;

COUNTERFEIT DRUGS; HEALTH POLICY; UNITED NATIONS; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 84887887645     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-11-233     Document Type: Article

References (51)

1. Attaran A, Barry D, Basheer S, Bate R, Benton D, Chauvin J, Garrett L, Kickbusch I, Kohler JC, Midha K, Newton PN, Nishtar S, Orhii P, McKee M. How to achieve international action on falsified and substandard medicines. BMJ 2012, 345:e7381. 10.1136/bmj.e7381, 23149211.
2. Mackey TK, Liang BA. The global counterfeit drug trade: patient safety and public health risks. J Pharm Sci 2011, 100:4571-4579. 10.1002/jps.22679, 21698604.
3. Mackey TK. Global health diplomacy and the governance of counterfeit medicines: a mapping exercise of institutional approaches. J Health Diplomacy 2013, 1.
4. Institute of Medicine Countering the problem of falsified and substandard drugs http://www.iom.edu/Reports/2013/Countering-the-Problem-of-Falsified-and-Substandard-Drugs.aspx, Institute of Medicine.
5. United Nations Office on Drugs and Crime Resolution 20/6: Countering fraudulent medicines, in particular their trafficking http://www.unodc.org/documents/commissions/CCPCJ/CCPCJ-ECOSOC/CCPCJ-ECOSOC-00/CCPCJ-ECOSOC-11/Resolution_20-6.pdf, United Nations Office on Drugs and Crime.
6. Interpol Pharmaceutical crime: A major threat to public health http://www.interpol.int/Crime-areas/Pharmaceutical-crime/Pharmaceutical-crime, Interpol.
7. World Health Organisation Options for the structure and governance of the Member State mechanism on substandard/spurious/ falsely-labelled/falsified/counterfeit medical products: Report by the Secretariat http://apps.who.int/gb/ssffc/pdf_files/A_MSM1_3-en.pdf, World Health Organisation.
8. International Federation of Pharmaceutical Manufacturers & Associations The IFPMA Ten Principles on Counterfeit Medicines http://www.ifpma.org/fileadmin/content/News/2010/IFPMA_Ten_Principles_on_Counterfeit_Medicines_12May2010.pdf, International Federation of Pharmaceutical Manufacturers & Associations.
9. World Customs Organization Cotonou Declaration against fake medicines, 12 October 2009, Cotonou (Benin) http://www.wcoomd.org/en/topics/enforcement-and-compliance/activities-and-programmes/~/media/WCO/Public/Global/PDF/Topics/Enforcement%20and%20Compliance/Activities%20and%20Programmes/IPR/Cotonou%20Declaration/Announcement%20on%20Cotonou%20Declaration%20UK.ashx, World Customs Organization.
10. Kingdon JW, Thurber JA. Agendas, Alternatives, and Public Policies, Update Edition, with an Epilogue on Health Care 2010, Addison-Wesley Longman.
11. World Health Organization Medicines: counterfeit medicines http://www.who.int/medicines/services/counterfeit/impact/ImpactF_S/en/index.html, World Health Organization.
12. World Health Organization Growing threat from counterfeit medicines. Bull World Health Organ 2010, 247-248. World Health Organization.
13. Fighting fake drugs: the role of WHO and pharma. Lancet 2011, 377:1626.
14. Organisation for Economic Co-Operation and Development The Economic Impact of Counterfeiting and Piracy 2008, 1-399. Paris, France: OECD Publishing, Organisation for Economic Co-Operation and Development, Organisation for Economic Co-Operation and Development.
15. Customs group to fight $200 bln bogus drug industry http://www.reuters.com/article/2010/06/10/us-customs-drugs-idUSTRE65961U20100610.
16. Gostin LO, Buckley GJ, Kelley PW. Stemming the global trade in falsified and substandard MedicinesStemming the global trade in substandard medicines. JAMA 2013, 309:1693-1694. 10.1001/jama.2013.3048, 23579391.
17. Cohen JC, Mrazek M, Hawkins L. Tackling corruption in the pharmaceutical systems worldwide with courage and conviction. Clin Pharmacol Ther 2007, 81:445-449. 10.1038/sj.clpt.6100074, 17251983.
18. World Health Organization Counterfeit medicines: an update on estimates 15 November 2006 http://www.who.int/medicines/services/counterfeit/impact/TheNewEstimatesCounterfeit.pdf, World Health Organization.
19. Liang BA, Mackey T. Searching for safety: addressing search engine, website, and provider accountability for illicit online drug sales. Am J Law Med 2009, 35:125-184.
20. Mackey TK, Liang BA. Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health. Global Health 2013, 9.
21. Campbell N, Clark JP, Stecher VJ, Goldstein I. Internet-ordered Viagra (sildenafil citrate) is rarely genuine. J Sex Med 2012, 9:2943-2951. 10.1111/j.1743-6109.2012.02877.x, 22925379.
22. Liang BA, Mackey TK. Vaccine shortages and suspect online pharmacy sellers. Vaccine 2012, 30:105-108. 10.1016/j.vaccine.2011.11.016, 22094281.
23. Forman RF. Availability of opioids on the internet. JAMA 2003, 290:889. 10.1001/jama.290.7.889, 12928464.
24. Forman RF, Block LG. The marketing of opioid medications without prescription over the internet. J Publ Pol Market 2006, 25:133-146.
25. Mackey TK, Liang BA. Oncology and the internet: regulatory failure and reform. J Oncol Pract 2012, 8:341-343. 10.1200/JOP.2012.000579, 3500477, 23450970.
26. Khan MH, Tanimoto T, Nakanishi Y, Yoshida N, Tsuboi H, Kimura K. Public health concerns for anti-obesity medicines imported for personal use through the internet: a cross-sectional study. BMJ Open 2012, 2.
27. Interpol Operations http://www.interpol.int/Crime-areas/Pharmaceutical-crime/Operations/Operation-Pangea, Interpol.
28. Pharmaceutical Security Institute Incident Trends http://www.psi-inc.org/incidentTrends.cfm, Pharmaceutical Security Institute.
29. Pharmaceutical Security Institute Counterfeit Situation: Therapeutic Categories http://www.psi-inc.org/therapeuticCategories.cfm, Pharmaceutical Security Institute.
30. Pharmaceutical Security Institute Counterfeit Situation - Definitions http://www.psi-inc.org/counterfeitSituation.cfm, Pharmaceutical Security Institute.
31. World Health Organization WHO's relationship with the International Medical Products Anti-Counterfeiting Taskforce http://apps.who.int/gb/ssffc/pdf_files/A_SSFFC_WG4-en.pdf, World Health Organization.
32. World Health Organization Substandard/Spurious/Falsely-Labelled/ Falsified/Counterfeit Medical Products: Report by the Director-General http://apps.who.int/gb/ebwha/pdf_files/WHA64/A64_16-en.pdf, World Health Organization.
33. Intellectual Property Watch WHO Members Show Dismay At Delay On Counterfeit Medicines Group http://www.ip-watch.org/weblog/2011/01/19/who-members-show-dismay-at-delay-on-counterfeit-medicines-group/, Intellectual Property Watch.
34. Mackey TK, Liang BA, Kubic TT. Dangerous doses: fighting fraud in the global medicine supply chain. Foreign Aff 2012
35. World Health Organization Conclusions and recommendations of the WHO international conference on combating counterfeit medicines: declaration of Rome http://www.who.int/medicines/services/counterfeit/RomeDeclaration.pdf, World Health Organization.
36. World Health Organization Sixty-Fifth World Health Assembly: Agenda item 13.13: WHA65.19 http://apps.who.int/medicinedocs/documents/s19994en/s19994en.pdf, World Health Organization.
37. World Health Organization Report of the First Meeting of the Member State mechanism on substandard/spurious/falsely- labelled/falsified/counterfeit medical products http://apps.who.int/gb/ssffc/pdf_files/A_MSM1_4-en.pdf, World Health Organization.
38. Mackey TK, Liang BA. A United Nations global health panel for global health governance. Soc Sci Med 2012, 76:12-15.
39. United Nations Office on Drugs and Crime Experts discuss the role of organized crime in the production and trade of fraudulent medicines http://www.unodc.org/unodc/en/frontpage/2013/February/conference-focuses-on-the-role-of-organized-crime-in-the-trafficking-of-fraudulent-medicines.html?ref=fs4, United Nations Office on Drugs and Crime.
40. United Nations Office on Drugs and Crime How UNODC deals with HIV http://www.unodc.org/unodc/hiv-aids/index.html, United Nations Office on Drugs and Crime.
41. United Nations Office on Drugs and Crime Think AIDS before you share needles http://www.unodc.org/unodc/en/frontpage/think-aids-before-you-share-needles.html, United Nations Office on Drugs and Crime.
42. United Nations Office on Drugs and Crime Criminals rake in $250 billion per year in counterfeit goods that pose health and security risks http://www.unodc.org/unodc/en/frontpage/2012/July/criminals-rake-in-250-billion-per-year-in-counterfeit-goods-that-pose-health-security-risks-to-unsuspecting-public.html, United Nations Office on Drugs and Crime.
43. Europol Europol and Interpol enhance cooperation against counterfeiting to transform regional success into global action https://www.europol.europa.eu/content/press/europol-and-interpol-enhance-cooperation-against-counterfeiting-transform-regional-suc, Europol.
44. Interpol Global operation strikes at online supply of illegal and counterfeit medicines worldwide http://www.interpol.int/News-and-media/News-media-releases/2011/PR081, Interpol.
45. Interpol Interpol and pharmaceutical industry launch global initiative to combat fake medicines http://www.interpol.int/News-and-media/News-media-releases/2013/PR031, Interpol.
46. World Health Organization WHO's role in the prevention and control of medical products of compromised quality, safety and efficacy such as substandard/spurious/falsely-labelled/ falsified/counterfeit medical products http://apps.who.int/gb/ssffc/pdf_files/A_SSFFC_WG2_3-en.pdf, World Health Organization.
47. World Intellectual Property Organization WHO, WIPO, WTO Trilateral Cooperation on Public Health, Intellectual Property and Trade http://www.wipo.int/globalchallenges/en/health/trilateral_cooperation.html, World Intellectual Property Organization.
48. United Nations Environmental Governance http://www.unep.org/pdf/brochures/EnvironmentalGovernance.pdf, United Nations.
49. United Nations Environment Programme United Nations Office for Partnerships http://www.un.org/partnerships/, United Nations Environment Programme.
50. World Health Organization Ninth meeting of the WHO Advisory Committee on Safety of Medicinal Products http://www.who.int/medicines/areas/quality_safety/safety_efficacy/ACSoMP9.pdf, World Health Organization.
51. World Trade Organization Doha 4th Ministerial - Ministerial declaration http://www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_e.htm, World Trade Organization.